首页> 外国专利> Citrullinated peptides derived from fibrin recognized by specific autoantibodies of rheumatoid arthritis and uses thereof.

Citrullinated peptides derived from fibrin recognized by specific autoantibodies of rheumatoid arthritis and uses thereof.

机译:类风湿关节炎特异性自身抗体识别的源自纤维蛋白的瓜氨酸化肽及其用途。

摘要

Peptide recognized by antiproteínas autoantibodies citrullinated (AAPC) present in the serum of patients affected by rheumatoid polyarthritis (RP), characterized in that it comprises at least one citrullyl residue and that is selected from the group consisting isolated by: a) a peptide defined by the sequence X 1PAPPPISGGGYX 2AX 3 (SEQ ID NO: 1) wherein X 1, X 2 and X 3 each represents a citrullyl residue or an arginyl residue and at least one of X 2 or X 3 radicals is a citrullyl residue; b) a defined by the sequence GPX 1VVEX 2HQSACKDS (SEQ ID NO peptide: 2) wherein X 1 and X 2 each represents a citrullyl residue or an arginyl residue and at least one of X 1 or X 2 moieties is a citrullyl residue; c) defined by a sequence SGIGTLDGFX1HX2HPD (SEQ ID NO peptide: 3) wherein X1 and X2 each represents a citrullyl residue or an arginyl and at least one of X 1 or X 2 moieties moiety is a citrullyl residue; d) a defined by the sequence VDIDIKIX1SCX2GSCS (SEQ ID NO peptide: 4) wherein X1 and X2 each represents a citrullyl residue or an arginyl and at least one of the radicals X1 or X2 moiety is a citrullyl residue; e) defined by the sequence X1GHAKSX2PVX3GIHTS (SEQ ID NO peptide: 12) wherein X1, X2 and X3 each represents a citrullyl residue or an arginyl residue and at least one of the radicals X1, X2 or X3 is a moiety citrullyl ; f) a peptide comprising at least 5 consecutive amino acids, including at least one previous citrullyl residue, of one of peptides a) to e).
机译:类风湿性多关节炎(RP)患者血清中存在的抗蛋白质自身抗体瓜氨酸化(AAPC)识别的肽,其特征在于它包含至少一个瓜氨酸残基,并且选自以下组成的组:a)序列X 1PAPPPISGGGYX 2AX 3(SEQ ID NO:1),其中X 1,X 2和X 3分别表示瓜酰基残基或精氨酰基残基,且X 2或X 3基团中的至少一个是瓜酰基残基; b)由序列GPX 1VVEX 2HQSACKDS(SEQ ID NO:2)定义,其中X 1和X 2各自代表瓜酰基残基或精氨酰基残基,并且X 1或X 2部分中的至少一个是瓜酰基残基; c)由序列SGIGTLDGFX1HX2HPD(SEQ ID NO:3)定义,其中X 1和X 2各自表示瓜酰基残基或精氨酰基,且X 1或X 2部分部分中的至少一个是瓜酰基残基; d)由序列VDIDIKIX1SCX2GSCS(SEQ ID NO:4)所定义,其中X 1和X 2各自表示瓜酰基残基或精氨酰基,且基团X 1或X 2部分中的至少一个是瓜酰基残基; e)由序列X1GHAKSX2PVX3GIHTS(SEQ ID NO:12)定义,其中X1,X2和X3各自代表一个瓜酰基残基或一个精氨酰基残基,并且基团X1,X2或X3中的至少一个是一个瓜酰基基团; f)一种肽,其包含肽a)至e)之一的至少5个连续氨基酸,包括至少一个先前的瓜酰基残基。

著录项

  • 公开/公告号ES2310853T3

    专利类型

  • 公开/公告日2009-01-16

    原文格式PDF

  • 申请/专利权人 BIOMERIEUX;

    申请/专利号ES20050815291T

  • 发明设计人 SERRE GUY;SEBBAG MIREILLE;

    申请日2005-11-03

  • 分类号C07K7/06;A61K39;C07K7/08;G01N33/53;

  • 国家 ES

  • 入库时间 2022-08-21 19:23:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号